关于2019年ESC/EAS血脂异常管理指南2025年重点更新的观点

IF 2 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Journal of Cardiovascular Medicine Pub Date : 2025-09-01 Epub Date: 2025-09-19 DOI:10.2459/JCM.0000000000001777
Kapka Miteva, Aliki Buhayer, Cédric Follonier, François Mach
{"title":"关于2019年ESC/EAS血脂异常管理指南2025年重点更新的观点","authors":"Kapka Miteva, Aliki Buhayer, Cédric Follonier, François Mach","doi":"10.2459/JCM.0000000000001777","DOIUrl":null,"url":null,"abstract":"<p><p>The 2025 Focused Update of the 2019  ESC/EAS Guidelines for the management of dyslipidaemias incorporates significant new evidence from major randomized controlled trials, as well as relevant systematic reviews and meta-analyses published since 2019 and up until 31 March 2025. The Update targets specific areas in which new data on prognostics models, diagnostic accuracy studies and therapeutics, including assessment of risk-benefit ratios, could immediately influence clinical practice, providing revised or new recommendations.</p>","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"26 9","pages":"473-476"},"PeriodicalIF":2.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Viewpoint on the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias.\",\"authors\":\"Kapka Miteva, Aliki Buhayer, Cédric Follonier, François Mach\",\"doi\":\"10.2459/JCM.0000000000001777\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The 2025 Focused Update of the 2019  ESC/EAS Guidelines for the management of dyslipidaemias incorporates significant new evidence from major randomized controlled trials, as well as relevant systematic reviews and meta-analyses published since 2019 and up until 31 March 2025. The Update targets specific areas in which new data on prognostics models, diagnostic accuracy studies and therapeutics, including assessment of risk-benefit ratios, could immediately influence clinical practice, providing revised or new recommendations.</p>\",\"PeriodicalId\":15228,\"journal\":{\"name\":\"Journal of Cardiovascular Medicine\",\"volume\":\"26 9\",\"pages\":\"473-476\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cardiovascular Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2459/JCM.0000000000001777\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2459/JCM.0000000000001777","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

2019年ESC/EAS血脂异常管理指南2025年重点更新纳入了来自主要随机对照试验的重要新证据,以及自2019年以来至2025年3月31日发表的相关系统评价和荟萃分析。《更新》针对一些特定领域,在这些领域,关于预后模型、诊断准确性研究和治疗方法(包括风险-效益比评估)的新数据可能会立即影响临床实践,并提供修订或新的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Viewpoint on the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias.

The 2025 Focused Update of the 2019  ESC/EAS Guidelines for the management of dyslipidaemias incorporates significant new evidence from major randomized controlled trials, as well as relevant systematic reviews and meta-analyses published since 2019 and up until 31 March 2025. The Update targets specific areas in which new data on prognostics models, diagnostic accuracy studies and therapeutics, including assessment of risk-benefit ratios, could immediately influence clinical practice, providing revised or new recommendations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Cardiovascular Medicine
Journal of Cardiovascular Medicine 医学-心血管系统
CiteScore
3.90
自引率
26.70%
发文量
189
审稿时长
6-12 weeks
期刊介绍: Journal of Cardiovascular Medicine is a monthly publication of the Italian Federation of Cardiology. It publishes original research articles, epidemiological studies, new methodological clinical approaches, case reports, design and goals of clinical trials, review articles, points of view, editorials and Images in cardiovascular medicine. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool. ​
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信